Jade Biosciences, Inc.
10-K
March 6, 2026
Key Highlights
- Lead drug candidate JB-101 is in Phase 2 clinical trials for Huntington's diseas...
- Reported a substantial 150% increase in revenue to $5.2 million, primarily from ...
- Maintained a strong cash position of $65.4 million, providing an estimated six-q...
Read Analysis
🤖 AI Generated